
An Open MDx Platform
Fully Automated Liquid Handling
and Ultra-Fast qPCR



Open – Low Cost – High-Throughput – Mobile – LIMS integrated – Compact
The NGX 124 is a fully open, automated molecular diagnostics (MDx) test platform, offering a significant advantage over other systems.
It supports all Laboratory Developed Tests (LDTs), Research Use Only (RUO), and approved assays sourced directly from a wide range of small and medium sized assay manufacturers.
Key benefits include
Technology
Jointly designed and developed by Fast MDx and Festo, the NGX 124 platform is the first fully automated, high-throughput, mobile Molecular Diagnostic (MDx) test platform and incorporates Fast MDx’s latest, ultra-fast, “NGx2” 4-Channel qPCR thermal cycler and Reverse Transcription “RT” block technology…







